You are here

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages

 

Online download statistics by month:

Online download statistics by month: March 2021 to July 2025

AbstractFullPdf
Mar 2021727727510
Apr 2021455455174
May 2021393393104
Jun 202125725796
Jul 202119920080
Aug 202120020087
Sep 202115315373
Oct 2021188188127
Nov 202117217376
Dec 202114114160
Jan 202212312564
Feb 2022112118112
Mar 2022133136111
Apr 202213313668
May 2022153154119
Jun 202213614378
Jul 202219219580
Aug 2022250254106
Sep 2022254256146
Oct 202214414680
Nov 202214214986
Dec 202210710960
Jan 2023989953
Feb 202312913163
Mar 202316817185
Apr 202310310379
May 202313613769
Jun 2023969652
Jul 202310810873
Aug 2023808145
Sep 202310110150
Oct 202313313474
Nov 202314614668
Dec 202313613891
Jan 202413113190
Feb 202413913966
Mar 202412512698
Apr 2024146146114
May 2024979876
Jun 202410410374
Jul 202412512877
Aug 202410210452
Sep 20241151181884
Oct 20241111121174
Nov 202413313597
Dec 202419619992
Jan 202512012177
Feb 202515916182
Mar 2025161161111
Apr 2025163164103
May 202513613690
Jun 202515715833
Jul 2025220
Total862086957689